Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation

The Karnataka government has offered a boost to health and lifescience firms, with an emphasis on infrastructure and innovation. With a grant of Rs. 300 crore and an allocation of Rs. 14,950,496 crore for healthcare, the state has asked...

Alkem Labs Enters into Ophthalmology with Launch of Eye Care Products

Alkem Labs has announced its entry into the field of ophthalmology with the release of a comprehensive portfolio of low-cost, high-quality eye care products. This strategic expansion demonstrates Alkem's dedication to innovation and meeting....

Asieris Pharma Completes Patient Enrollment in Hexvix's Phase III Bridging trial for the Diagnosis of Bladder Cancer

Asieris Pharmaceuticals, a global biopharmaceutical company specialising in the discovery, development, and commercialization of innovative drugs for the treatment of genitourinary tumours and other related diseases, announced the completion...

India is emerging as a Preferred Destination for CRAMS due to a combination of factors, say Experts

Indian pharmaceutical & nutraceutical companies are increasingly recognizing the advantages of outsourcing various aspects of their operations, intensifying their focus on this strategic approach to offer a competitive cost structure, which makes ...

Moderna Signs an Agreement with China to Develop mRNA Medicines

Moderna Inc, a vaccine manufacturer, announced earlier this week that it had signed a memorandum of understanding and a land collaboration agreement to explore opportunities to research, develop, and manufacture mRNA medicines in China...

Dr. Reddy's made its Debut in the Child Nutrition Market in India with the launch of CeleHealth Kidz Gummies

In India, Dr. Reddy's Laboratories has introduced CeleHealth Kidz Immuno Plus Gummies. Immunity-boosting gummies are fortified with a scientifically designed blend of ingredients including Wellmune, prebiotics, and other essential vitamins and...

Biocon Biologics Completes Integration of acquired Biosimilars Business in 70+ Emerging Markets Nations

Biocon Biologics Ltd said that it has completed the integration of the acquired biosimilars business in over 70 countries in Emerging Markets, which will take effect on July 1, 2023, enhancing the company's scale and breadth...

BDR Pharma Launches Nilotinib for the Treatment of Philadelphia Chromosome-positive Leukaemia

BDR Pharmaceuticals, a leading pharmaceutical firm has announced the launch of Nilotinib to treat a rare subtype of acute lymphoblastic leukaemia, the most common childhood cancer.PH+ leukaemia, which includes acute lymphoblastic leukaemia (ALL)....

Venus Remedies Oncology Wing Expands with GCC, ASEAN, Balkan, and Caribbean Marketing Approvals

Venus Remedies, a global provider of affordable cancer drugs, has strengthened its position in the Gulf Cooperation Council (GCC), Association of South East Asian Nations (ASEAN), Balkan, and Caribbean regions with marketing approvals...

FDI Equity Inflow into Pharma Sector registers Growth of 45% in FY 23 to cross $2 Billion Mark

The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical industry has registered a growth of 45.4 per cent in the fiscal year ended March, 2023, as compared to the inflow in the previous fiscal year. The foreign equity investment ...

© 2024 India Pharma Outlook. All Rights Reserved.